Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 10/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GALK1 | P51570 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | PLEC | Q15149 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3073675 | 0.82 | MAPT (0.56) | TDP1KMT2AMEN1LMNAMAPT | |
| SCHEMBL5925633 | 0.78 | TERT (0.37) | MCHR1SMN1; SMN2 | |
| SCHEMBL20335185 | 0.77 | ALDH1A1 (0.37) | MCHR1KMT2AKDM4EMEN1SMN1; SMN2 | |
| SCHEMBL5583042 | 0.76 | TDP1 (0.81) | MCHR1TDP1KMT2AKDM4EMEN1 | |
| SCHEMBL5582801 | 0.76 | MCHR1 (0.55) | MCHR1TDP1GALK1CASP6MCL1 | |
| SCHEMBL3296397 | 0.74 | KMT2A (0.83) | TDP1GALK1CASP6MCL1PLEC | |
| SCHEMBL13656220 | 0.74 | MCHR1 (0.49) | MCHR1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL5582633 | 0.74 | SMN1; SMN2 (0.69) | MCHR1TDP1KMT2AKDM4EMEN1 | |
| SCHEMBL13660199 | 0.73 | MCHR1 (0.79) | MCHR1KMT2AKDM4EMEN1LMNA | |
| SCHEMBL6925692 | 0.73 | MCHR1 (0.92) | MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070173498-A1 | Melanin concentrating hormone antagonist | KATO KANEYOSHI | 2007-07-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173498-A1 | Melanin concentrating hormone antagonist | MC1R, MCHR1, MCHR2 | MCHR1 2/4885TDP1 4545/4885GALK1 4443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.